Pharmaceutical Technology
MAY 24, 2023
Nearly every biopharma with a portfolio of drugs in development spanning traditional small molecules and biologics and the newer CGT operates with separate clinical supply organizations per these therapy areas. This is due to major differences throughout the clinical supply chain in both requirements and management practices.
Pharmaceutical Technology
SEPTEMBER 20, 2022
The list includes clinical packaging service contractors with expertise in material science, industrial design and information technology and providing innovative and cost-effective clinical trial packaging solutions. Clinical trial packaging and labelling solutions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
AUGUST 10, 2022
A good CMO can assist with everything from clinical supply and formulation challenges to risk mitigation, as well as general challenges that can arise through the scale-up process, such as market demand fluctuation. Drawings and/or part numbers of the selected container closure? Packaging needs?. Reviewing proposals???.
The Pharma Data
JANUARY 10, 2021
Monjuvi (R) is a registered trademark of MorphoSys AG. Tremfya (R) is a registered trademark of Janssen Biotech, Inc.
The Pharma Data
NOVEMBER 22, 2020
Molecular Partners is also collaborating with AGC Biologics, Baccinex, and Ivers-Lee Clinical Supply Management (IL-CSM) to support development of its anti-COVID-19 program, and has reached an agreement with the Swiss Government regarding rights to purchase up to 3.2 million doses of MP0420, if it is approved in Switzerland.
The Pharma Data
NOVEMBER 18, 2020
These restrictions and uncertainty around the duration, severity and geographic scope of the COVID-19 outbreak are projected to slow down the enrolment of patients due to re-prioritisation of hospital activities towards COVID-19 patients and away from clinical studies such as PARADIGME. Forward-looking statements.
The Pharma Data
OCTOBER 27, 2020
During the clinical development stage, Molecular Partners will provide clinical supply. The companies will work together to scale-up manufacturing capacity, in collaboration with Sandoz, the generics and biosimilar Novartis division, to provide worldwide supply. Forward-looking statements.
Expert insights. Personalized for you.
246 
Let's personalize your content